11/18/2025
💙 Elfabrio®: Advancing Care for Fabry Disease 💉
Elfabrio® (pegunigalsidase alfa) is an enzyme replacement therapy approved for adults with confirmed Fabry disease — a rare genetic condition affecting multiple organs over time.
✨ Administered as an IV infusion every two weeks
✨ Dosed based on patient weight
✨ Replaces the missing enzyme responsible for breaking down certain fatty substances
✨ Helps supports organ health and long-term disease management
At Sage Infusion we administered Elfabrio. Please check with your healthcare professional to see if Elfabrio is right for you.
📩 Physicians, send your referrals today and partner with us in delivering exceptional care. https://sageinfusion.com/SubmitOrder/